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Abstract
Delayed wound healing is one of the most common secondary adverse effects associated to the therapeutic use of
glucocorticoid (GC) analogs, which act through the ligand-dependent transcription factor GC-receptor (GR). GR function is
exerted through DNA-binding-dependent and –independent mechanisms, classically referred to as transactivation (TA) and
transrepression (TR). Currently both TA and TR are thought to contribute to the therapeutical effects mediated by GR;
however their relative contribution to unwanted side effects such as delayed wound healing is unknown. We evaluated skin
wound healing in transgenic mice with keratinocyte-restricted expression of either wild type GR or a mutant GR that is TA-
defective but efficient in TR (K5-GR and K5-GR-TR mice, respectively). Our data show that at days (d) 4 and 8 following
wounding, healing in K5-GR mice was delayed relative to WT, with reduced recruitment of granulocytes and macrophages
and diminished TNF-a and IL-1b expression. TGF-b1 and Kgf expression was repressed in K5-GR skin whereas TGF-b3 was up-
regulated. The re-epithelialization rate was reduced in K5-GR relative to WT, as was formation of granulation tissue. In
contrast, K5-GR-TR mice showed delays in healing at d4 but re-established the skin breach at d8 concomitant with
decreased repression of pro-inflammatory cytokines and growth factors relative to K5-GR mice. Keratinocytes from both
transgenic mice closed in vitro wounds slower relative to WT, consistent with the in vivo defects in cell migration. Overall,
the delay in the early stages of wound healing in both transgenic models is similar to that elicited by systemic treatment
with dexamethasone. Wound responses in the transgenic keratinocytes correlated with reduced ERK activity both in vivo
and in vitro. We conclude that the TR function of GR is sufficient for negatively regulating early stages of wound closure,
while TA by GR is required for delaying later stages of healing.
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Introduction
Glucocorticoid (GC) derivatives are widely used as therapeutic
agents in acute and chronic inflammatory diseases due to their
anti-inflammatory properties [1]. However, unwanted side-effects,
such as delayed wound healing, are very common, limiting their
long-term use [1–3]. GCs act through the ubiquitously expressed
intracellular GC receptor (GR), encoded by a single gene in
humans and mice called Nr3c1. Nr3c1 transcripts undergo both
alternative splicing and alternative translational initiation, result-
ing in multiple GR protein isoforms [4]. GRa, which we will refer
to as GR, is the predominant mRNA isoform in most cell types
and its protein products are able to bind endogenous or synthetic
ligands. After binding GCs, GR dissociates from cytoplasmic
complexes, dimerizes and translocates to the nucleus, where it
modulates gene transcription [5]. GR monomers or dimers can
bind to GC-response elements or GREs located in target genes
[6]. Besides DNA-binding-dependent transcriptional regulation,
GR also regulates gene expression by interfering with other
transcription factors, such as NF-kB, AP-1 or STATs, without
direct binding to DNA [7,8].
The mechanisms of GR-mediated regulation are classically
referred to as transactivation (TA; dimerization- and DNA-
binding-dependent) and transrepression (TR; DNA-binding-inde-
pendent). The genetic dissection of TA and TR functions has
contributed to a better understanding of the mechanisms of GR
action. A great deal of work has been performed with GRdim/dim
mice that harbor a point mutation (A458T) in the DNA binding
domain of GR, abrogating dimerization-dependent TA [9]. In
contrast to GR2/2 mice, which die perinatally from respiratory
distress, GRdim/dim mice survive, thus allowing studies in adult
animals [10,11]. Other GR mutants with compromised TA that
retain their capacity for TR have been reported, including
P493R/A494S [12], here referred to as GR-TR. Classically, the
therapeutical actions of GR have been ascribed to TR and the
adverse side-effects have been linked to TA, however, the scenario
is far more complex. More recent studies demonstrate that both
TA and TR contribute to GR’s anti-inflammatory effects, for
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instance, through the induction of genes such as Mkp-1 and Ikba
[13,14].
Cutaneous wound healing is a complex process aimed to repair
tissue damage and restore skin homeostasis. There are three
phases in wound healing that require a coordinated interaction
among diverse cell types with precise kinetics: inflammation, re-
epithelialization and tissue remodeling [15,16]. In all phases of
wound healing, growth factors and cytokines play a major role
[16]. The first phase of wound repair is inflammation, and is
characterized by platelet aggregation followed by recruitment of
leukocytes including macrophages and neutrophils at to the injury
site. The release of cytokines and growth factors amplifies the
inflammatory response and initiates the formation of the
granulation tissue. This phase is key for subsequent re-epithelial-
ization and remodeling and thus constitutes a target for
modulating the outcome of the healing response. Re-epithelial-
ization requires both proliferation and migration of keratinocytes,
and is normally accompanied by formation of new granulation
tissue. After re-epithelialization is completed, keratinocytes must
stratify and differentiate to restore the barrier. The granulation
tissue has to be replaced by extracellular matrix proteins such as
collagen and elastin to achieve complete tissue remodeling.
Previous work has evaluated the mechanisms by which GR
action inhibits healing by using rodent models treated with GC
analogs, mainly Dexamethasone (Dex) [17]. In this work, we
assessed the consequences of constitutive, keratinocyte-specific
expression of the wt GR or the GR-TR mutant on the wound
healing process. For this purpose, we have used the transgenic
mouse lines K5-GR and K5-GR-TR, in which both transgenes
are under the control of the same tissue-specific promoter
achieving similar expression levels of the WT and mutant GR
proteins [18,19].
Altogether, our data indicate that keratinocyte-targeted over-
expression of either GR or GR-TR was sufficient to repress re-
epithelialization at early timepoints following wounding. Both
transgenes inhibited keratinocyte proliferation and migration to a
similar extent relative to controls. However, the repression of
several cytokines and growth factors associated with wound repair
was more pronounced in K5-GR mice than in K5-GR-TR mice.
Despite the initial delay in re-epithelialization, K5-GR-TR, but
not K5-GR, mice were eventually able to heal wounds with similar
kinetics as WT. In vitro wound scratch assays using cultured
keratinocytes isolated from K5-GR and K5-GR-TR mice
recapitulated the in vivo observations.
Results
We analyzed the kinetics of healing in K5-GR and K5-GR-TR
mice relative to WT littermates after excision wounds were made
on dorsal skin. In both mouse lines, transgenes were expressed at
similar levels in keratinocytes (Fig. 1A and [18,19]). The wound
sites were photographed at the indicated times and the wound area
at each time point was compared to that of the original excision
(Fig. 1B, C). The wounds of K5-GR and K5-GR-TR healed
slower than those of WT (17% and 8%, respectively) at d4.
However, at d8, only K5-GR showed delayed wound healing
whereas K5-GR-TR wounds were similar to those of WT (Fig. 1C).
Immunostaining shows that endogenous GR was mostly localized
in the cytoplasm of all epidermal layers and hair follicles (HF) of
WT and transgenic mice. In transgenic mice, GR and GR-TR
were constitutively nuclear in the basal keratinocytes of the
epidermis and HF (Fig. 1D, IH GR; [18,19]). Histological
comparison of the wounds demonstrated that overexpression of
both GR and GR-TR in keratinocytes caused an impaired healing
response at d4 (Fig. 1D). This delay in healing persisted at d8 in
K5-GR mice (Fig. 1D). Wound re-epithelialization was evaluated
by measuring the re-epithelialized edges (arrows) relative to those
of the original wounds (arrowheads) (Fig. 1D and 1E). In WT at
d4, well developed epithelial tongues were observed at both sides
of the wound center. At d8, WT wounds were closed although
epidermal hyperplasia persisted adjacent to the wound and de novo
hair follicle formation had not yet occurred (Fig. 1D). In contrast,
at d4 the keratinocytes had not begun migrating into the wound
bed in K5-GR and K5-GR-TR wounds and the percentage of re-
epithelialization relative to WT was greatly reduced (Fig. 1D and
1E). However, the delayed wound healing only persisted at d8 in
K5-GR mice whereas K5-GR-TR wounds were closed at that
stage similar to WT mice (Fig. 1D and E). Trichrome staining in
d8 wounds showed a reduced collagen content in the granulation
tissue of K5-GR transgenic mice (Figure 1D, circled). Altogether,
these data indicate that keratinocyte-targeted overexpression of
GR and GR-TR is sufficient to repress early re-epithelialization.
However, only GR was able to reduce collagen deposition at later
stages of wound healing.
Since re-epithelialization depends on proliferation and migra-
tion of keratinocytes, we examined these processes in the wounds
of K5-GR and K5-GR-TR. We assessed keratinocyte migration
by evaluating the architecture of the epithelial tongue and the
expression of K6 by immunostaining (Fig. 2, K6). Immunolocal-
ization of the epidermal differentiation marker K10 was assessed
in serial sections of skin wounds (Fig. 2, K10). In WT at d4, the tip
of migrating keratinocytes stained positive for K6 and negative for
K10 (Fig. 2, d4, WT; arrow indicates the migrating tip).
The hyperplasic skin adjacent to the wound also expressed K6
in all epidermal layers, which decreased progressively distal to the
wound coincident with increased K10 expression (Fig. 2, d4, WT;
see insets). In contrast, wounds of K5-GR and K5-GR-TR only
had incipient epithelial tongues (Fig. 2, d4, K6, asterisks), with
more restricted K6 staining adjacent to the wound. Contrary to
WT, K10 expression was detected continuously throughout the
skin of K5-GR and K5-GR-TR mice, with the exception of the tip
of the epithelial tongues (Fig. 2, d4, K10). In contrast at d8, only
overexpression of GR interfered with keratinocyte migration, as
shown by reduced K6 immunostaining in K5-GR wounds relative
to WT and K5-GR-TR (Fig. 2, d8). The lack of continuous K10
staining in K5-GR d8 wounds indicated that the restoration of the
epidermal barrier was still incomplete. Remarkably, the delayed
wound healing of K5-GR mice closely mimicked the healing
response of WT mice treated with Dex for 7 d prior to wounding,
as shown by K6 and K10 immunostaining (Fig. 3).
Proliferation in the wounds was quantified by counting BrdU-
labeled nuclei in the basal keratinocyte layer from the BrdU-
labeled keratinocyte most proximal to the wound margin to the
area at which the BrdU labeling index fell below 5% [20]. There
was a statistically significant reduction in keratinocyte proliferation
in the wounds of both K5-GR (23%) and K5-GR-TR (15%) mice
relative to WT (37%) at d4 after wounding (Fig. 4A). The growth
rate paralleled the observed differences in epidermal hyperplasia,
which was more pronounced and sustained in the injured skin in
WT than in transgenic mice (Fig. 2). At later stages of the wound
repair, the rate of keratinocyte proliferation was equivalent in all
genotypes (Fig. 4A). Altogether, our results show that overexpres-
sion of either GR or GR-TR inhibits keratinocyte proliferation
and migration, and induce differentiation, resulting in delayed
healing.
It is well known that many of the anti-inflammatory properties
of GR reside in its TR function; however, increasing evidence
indicates that TA also plays an important role [13,14]. We
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examined and compared the immune infiltrate in K5-GR and K5-
GR-TR mice during wound healing by immunostaining with
specific antibodies for markers of granulocytes (Ly6G), and
macrophages (F4/80). Most granulocytes were present within
the clot 4 days after wounding, making it difficult to assess cell
number. Nonetheless, neutrophil recruitment was reduced in the
skin of transgenic animals (Fig. 4B, d4, arrows). At d8, neutrophils
were only detected at the wound scab of K5-GR, consistent with
the delayed kinetics of healing (Fig. 4B, d8, arrows). Macrophage
recruitment in wounded skin was strongly reduced in K5-GR and
K5-GR-TR relative to WT (Fig. 4B, d4, see inset for higher
magnification). At d8, macrophages were reduced in both
transgenics relative to WT, being virtually absent in K5-GR mice
(Fig. 4B, d8). We also examined the expression of TNF-a by
immunohistochemistry and assessed the staining specificity by
using a negative control (secondary antibody only) along with a
positive control (a PMA-treated WT mouse skin section), as shown
in Fig. S1. We observed reduced levels of this pro-inflammatory
cytokine in K5-GR and K5-GR-TR injured skin relative to WT at
d4. However, TNF-a down-regulation was more evident in K5-
GR than in K5-GR-TR. At d8, we detected similar weak
expression of this cytokine in all genotypes (Fig. 4B). Altogether,
our data indicate that at later stages, the healing response of K5-
GR-TR mice was more similar to WT than to K5-GR.
Given that the many of the growth factors and cytokines playing
a major role in wound healing are repressed by GCs, we examined
the expression of several of these genes by quantitative RT-PCR.
We checked gene expression of Tnf-a, Il-1b, Tgf-b1, Tgf-b3 and
Kgf before and after wounding (Fig. 4C). In uninjured skin of all
genotypes, there were no statistically significant changes in gene
expression with the exception of Tgf-b1 and Tgf-b3. Tgf-b1 was
slightly increased in K5-GR-TR skin relative to WT and K5-GR
mice whereas Tgf-b3 was up-regulated in both transgenics relative
to WT.
Figure 1. In vivo overexpression of GR and GR-TR in keratinocytes delays wound healing with different kinetics of repair. A) Similar
transgene expression in K5-GR and K5-GR-TR mice. Relative protein levels of the transgene vs endogenous GR were determined by immunoblotting
using an antibody that recognizes both mouse (endogenous) and rat (transgene) GR. Actin was used as a loading control. A representative panel of
three independent experiments and quantitation of three independent experiments is shown. Statistical significance was assessed by ANOVA
(**p,0.01). B) Macroscopic changes in full-thickness cutaneous wounds. The wound sites were photographed at the time indicated after wounding.
Representative results from 12 mice of each genotype are shown. C) The percentage of wound closure area at each time point was estimated relative
to the original wound area. Values represent mean 6 SD (n=12 for all groups). Statistical significance was determined using ANOVA (*p,0.05,
**p,0.01). D) Histological evaluation of skin wounds in WT, K5-GR and K5-GR-TR mice at d4 and 8 after injury. Arrowheads and arrows indicate
original wound edges and re-epithelialized edges, respectively. Trichrome staining shows distinct collagen deposition in the dermis at d8 in the
indicated genotypes. Immunostaining using an anti-GR specific antibody shows GR expression and localization in WT vs transgenic mice (IH: GR).
Note the nuclear localization of GR in both transgenic skin samples. Hematoxylin/eosin and Trichrome staining, Bars: 100 mm; IH: GR, Bar: 50 mm. E)
The percentage of re-epithelialization was evaluated in WT, K5-GR and K5-GR-TR mice at d4 and d8 after wounding. All values represent the mean
6SD (n= 12 for all groups). Statistical significance was estimated using ANOVA (*p,0.05, **p,0.01).
doi:10.1371/journal.pone.0029701.g001
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In WT wounds, the expression of all genes analyzed was
induced at d4. At d8 mRNA levels of all genes declined, with the
exception of Tgf-b1. In K5-GR d4 wounds, the expression of Tnf-
a, Il-1b and Kgf was repressed in comparison to WT, whereas Tgf-
b3 mRNA was up-regulated. At d8, transcript levels were similar
in K5-GR and WT mice for all the genes analyzed except for Tgf-
b1, which was down-regulated in K5-GR wounds. Importantly,
we observed differences in the amplitude and kinetics of the
Figure 2. Reduced migration and increased differentiation of keratinocytes in K5-GR wounds relative to K5-GR-TR and WT mice.
Skin wounds were collected from WT, K5-GR or K5-GR-TR mice at d4 and d8 to evaluate the expression of K6 and K10 by immunostaining using
specific antibodies. Representative results from 5 mice of each genotype are shown. The arrow indicates the migrating tip of the WT wound and the
asterisks indicate the impaired keratinocyte migration in the transgenics. Boxed areas are enlarged. Higher magnification of boxed areas is at the
lower right of each image. Bar: 100 mm.
doi:10.1371/journal.pone.0029701.g002
Figure 3. Delayed wound healing response in K5-GR mice is equivalent to that of Dex-treated WT mice. Histological analysis of re-
epithelialization of skin wounds in WT mice untreated or treated with Dex (1 mg/kg/day) for 7 d before wounding, at d9 after injury. Arrowheads
indicate original wound edges. Immunostaining using anti-K6 and anti-K10 specific antibodies shows the delayed healing in Dex-treated vs untreated
WT mice (n= 6). Representative images of three independent experiments are shown. Bar: 100 mm.
doi:10.1371/journal.pone.0029701.g003
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response in GR and GR-TR transgenic mice. In d4 K5-GR-TR
wounds, Il-1b was repressed to a lesser extent than in K5-GR
wounds. However, unlike in K5-GR mice, the repression of Il-1b
continued at d8. Importantly, Tnf-a, Kgf and Tgf-b1 mRNA levels
were not repressed in K5-GR-TR wounds and were similar to
those of WT.
The antagonism between GR and the MAPK ERK has been
reported in several cell types, including keratinocytes [1,21,22].
We assessed whether impaired ERK activity was involved in the
wound delay elicited by GR and GR-TR in vivo by analyzing the
relative levels of ERK and p-ERK and downstream targets c-Fos
and cyclin D1 by immunoblotting. The ratio of phosphorylated
(p)-ERK/ERK was significantly increased in WT mice at d8
following wounding whereas both transgenic mice showed
statistically significant decrease in ERK activity relative to WT
wounds at d4 and d8 (Fig. 5A, B). Remarkably, the decrease in
phospho-ERK at d8 was more pronounced in K5-GR than in K5-
GR-TR mice. Following ERK activation, c-Fos and cyclin D1
were induced in WT skin at d8 upon wounding (Fig. 5A, B). In
contrast, c-Fos and cyclin D1 were significantly down-regulated
relative to WT in both transgenics to the same extent at this
timepoint.
Previous reports have described a cross-talk between GR and b-
catenin in wound responses [23]. We thus checked whether K5-
GR and K5-GR-TR mice have altered expression and/or
localization of b-catenin upon wounding. In d4 WT wounds, b-
catenin was found at the membrane of suprabasal keratinocytes
and in the cytoplasm of more basal epidermal layers (Fig. 5C). In
contrast, we detected b-catenin mostly in the cytoplasm of
epidermal keratinocytes but also in some nuclei of the transgenics
(Fig. 5C, d4). At d8 after wounding, we did not find differences in
b-catenin localization among all genotypes. However, b-catenin
Figure 4. K5-GR and K5-GR-TR mice exhibit reduced proliferation and inflammatory response following injury. A) Keratinocyte
proliferation in WT and transgenic wounds. The proliferation rate was quantified by counting BrdU-labeled nuclei in the basal layer of interfollicular
epidermal keratinocytes at d4 and d8. Positive nuclei were counted from the BrdU-labeled keratinocyte most proximal to the wound margin to the
area at which the BrdU labeling index fell below 5%. The graph illustrates the percentage of positive BrdU keratinocytes vs total nuclei. Mean values
6 SD are shown (n= 36). Asterisks denote statistically significant differences among genotypes within a given timepoint, as determined by ANOVA
(*, p,0.05; **, p,0.01). B) Cutaneous inflammation in WT and transgenic wounds. Immunostaining of WT, K5-GR and K5-GR-TR wounds at d4 and d8
showing granulocytes (Ly6G, arrows), macrophages (F4/80) (inset), and TNF-a (inset). Representative images of three independent experiments are
shown. Bar: 50 mm. C) Altered gene expression in transgenic skin wounds. Transcript levels of Tnf- a, Il-1 b, Tgf-b1, Tgf-b3, and Kgf were determined in
the wounds of the indicated genotypes at d4 and d8 after injury by quantitative RT-PCR. Experiments were performed using at least three individuals
of each genotype per timepoint. The mRNA levels of WT mice before wounding for each gene were set to 100, and fold-changes related to this basal
level. Mean values 6 SD are shown. Asterisks denote statistically significant differences among genotypes for each gene at a given timepoint, as
determined by ANOVA (*, p,0.05; **, p,0.01).
doi:10.1371/journal.pone.0029701.g004
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expression levels were decreased in K5-GR wounds relative to the
other genotypes (Fig. 5C, d8).
To further evaluate the keratinocyte-specific contribution of GR
and GR-TR in delayed healing, we performed wound scratch assays
in primary cultured keratinocytes obtained from K5-GR, K5-GR-
TR and WT mice and assessed cell migration (Fig. 6A, B). At 8 h
after scratching, we found a significant reduction of keratinocyte
migration in both K5-GR and K5-GR-TR cultures relative to WT
(20% and 35%, respectively, in comparison to 55%). This trend
was still apparent at 24 h (77% and 84% in K5-GR and K5-GR-
TR cells, relative to 100% in WT cells); however, the delay in
migration was only statistically significant in K5-GR keratinocytes
relative to WT.
We next assessed the activity of ERK and AKT by
immunoblotting shortly (1 h) after scratch wounding transgenic
and WT keratinocytes (Fig. 6C). The p-ERK/ERK ratio was
significantly diminished in K5-GR keratinocytes relative to WT,
before and after the scratch. In contrast, ERK activity in K5-GR-
TR keratinocytes was more similar to that observed in WT.
Statistically significant increases in AKT activity following in vitro
wounding were only observed in WT and K5-GR keratinocytes
(Fig. 6C). At t1, the p-AKT/AKT ratio was reduced in K5-GR
and K5-GR-TR relative to WT and remarkably, the differences
between the two transgenic lines were also statistically significant
(Fig. 6C). Overall, our data suggest that distinct patterns of ERK
and AKT inhibition mediated by GR and GR-TR in keratino-
cytes may contribute to the differential wound responses of each
transgenic mouse line.
Discussion
Prolonged GC therapy in human patients is often accompanied
by adverse reactions including skin atrophy and delayed wound
healing [2]. It has been also reported that psychological stress,
likely through the increased production of endogenous GCs,
disturbs epidermal barrier competence [24]. Previous efforts to
identify the mechanisms responsible for the adverse actions
mediated by GR in wound repair relied on the use of synthetic
ligands for GR either in vivo or in cultured keratinocytes [2,23]. In
this work, we have investigated the effects of keratinocyte-specific
expression of the wild-type and mutant forms of GR in wound
repair. In both mouse models, the keratinocyte-targeted expression
of either GR or GR-TR resulted in nuclear localization of the
transgenes, as shown by immunolocalization studies in vivo (Fig. 1C;
[18,19]. Remarkably, the phenotype of K5-GR and K5-GR-TR
mice recapitulates the skin atrophy and sporadic alopecia observed
after prolonged treatments with GC analogs in human patients as
both transgenic mice featured epidermal thinning as well as
diminished number of hair follicles in the adult age [2,18,25].
These alterations were exclusively due to the transgenes and not
related to changes in the endogenous circulating GC levels, as
plasma corticosterone levels were unchanged in the transgenics
Figure 5. K5-GR and K5-GR-TR wounds show reduced ERK activity. A) Changes in protein expression after wounding. Total skin protein was
extracted from d4 and d8 wounds of WT, K5-GR and K5-GR-TR mice and subjected to immunoblotting using the indicated specific antibodies (p-ERK,
ERK, c-Fos, and cyclin D1). Actin was used as a loading control. Panels are representative of the relative expression levels of the indicated proteins for
each condition. B) Quantitation of the experiments performed using at least three individuals of each genotype per timepoint. Protein levels were
normalized to actin. The graph shows the p-ERK/ERK ratio as well as c-Fos and cyclin D1 protein levels in K5-GR, K5-GR-TR and WT wounds. The
protein levels of WT mice before wounding were set to 100, and fold-induction related to this basal level. Mean values 6SD are shown. Asterisks
denote statistically significant differences at each timepoint among all genotypes, as determined by ANOVA (*, p,0.05; **, p,0.01). C)
Immunostaining of sections of WT, K5-GR and K5-GR-TR wounds at d4 and d8 showing the expression pattern of b-catenin. Arrows denote the
nuclear localization of b-catenin in transgenic keratinocytes. Representative images of each condition are shown. Bar: 50 mm.
doi:10.1371/journal.pone.0029701.g005
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relative to WT mice (data not shown). However, the existence of
extra-adrenal additional sources of GC synthesis, including the
skin [26], needs to be taken into account. Recent work has shown
that epidermal keratinocytes can synthesize de novo cortisol, as well
as other steroid metabolizing enzymes, both in vitro and in vivo [27].
Furthermore, it was shown that IL-1b synthesis, one of the first
events occurring in keratinocytes upon injury, triggers the local
production of cortisol. Conversely, augmented IL-1b during
wound healing resulted in the inhibition of cortisol synthesis. This
highlights the relevance of locally produced GCs and likely
represents a feed-back mechanism to modulate GC-mediated
signaling and mitigate the initial pro-inflammatory responses [27].
There were statistically significant delays in transgenic wound
closure relative to WT. In fact, the slowed healing elicited by the
keratinocyte-targeted overexpression of GR in K5-GR mice was
very similar to that observed in WT mice that were Dex-treated
prior to wounding (Fig. 3). This implies that at least some of the
side-effects associated with GC treatment, such as delayed wound
healing, are mediated through keratinocyte autonomous GR
actions. Overall, our results highlight that K5-GR and K5-GR-
TR mice are valuable tools to address the molecular mechanisms
underlying keratinocyte-specific GR effects in skin homeostasis.
It is known that several pro-inflammatory cytokines such as IL-
1a, IL-1b, IL-6, and TNF-a are typically up-regulated during the
inflammatory phase of wound healing, contributing to normal
repair [15,16]. Among these, IL-1b plays a key role in epidermal
injury, being one of the first signals activated in keratinocytes. The
expression of these cytokines as well as the termination of the
inflammatory response through induction of anti-inflammatory
cytokines such as IL-10 must be spatio-temporally coordinated
[16]. TNF-a and IL-1b mRNA were induced in WT mice at d4,
consistent with the literature (Fig. 4). However, in d4 wounds, the
transcript levels of TNF-a were significantly diminished in K5-GR
as compared to WT and K5-GR-TR mice. The decrease in
induction of IL-1b was pronounced in both transgenic mice
relative to WT at d4; however, at d8 only K5-GR-TR showed a
significant decrease in IL-1b mRNA. These changes are in
agreement with the strong reduction of several pro-inflammatory
cytokines including IL-1b reported in Dex-treated mice as well as
in diabetic db/db mice [17]. Our previous work illustrated that the
mechanism(s) used by GR for TR in keratinocytes is gene-specific,
as GR-TR efficiently repressed IL-1b and Mmp-3 transcription (to
a similar extent as GR) whereas it only weakly repressed that of IL-
6 and TNF-a [18].
As macrophages and neutrophils are major sources of IL-1b, the
changes in expression in transgenic wounds may be due to either
reduced recruitment of inflammatory cells and/or direct repres-
sion of IL-1b by GR and GR-TR in keratinocytes. Our
Figure 6. GR and GR-TR delay keratinocyte migration in in vitrowound scratch assays. A) In vitro migration of K5-GR and K5-GR-TR primary
keratinocytes isolated from WT, K5-GR and K5-GR-TR were evaluated for in vitro wound closure at 8 h and 24 h following scratching. Phase contrast
photographs are representative of four independent experiments. Bar: 100 mm. B) The graph shows the average of wound closure 6 SD. Statistically
significance was determined by ANOVA (*, p,0.05; **, p,0.01). The percentage of cell migration was estimated as described in Materials and
Methods. C) Quantitation of the p-ERK/ERK and p-AKT/AKT ratios in WT, K5-GR and K5-GR-TR keratinocytes before (t0) and after (t1) scratch
wounding. Protein levels were determined by immunoblotting using specific antibodies against the total and phosphorylated proteins, and then
normalized to actin. Mean values 6 SD are shown. Asterisks denote statistically significant differences, as determined by ANOVA (*, p,0.05;
**, p,0.005).
doi:10.1371/journal.pone.0029701.g006
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immunodetection data showing clear reductions in the dermal
inflammatory infiltrate in both transgenics relative to WT
correlate well with RT-PCR results (Fig. 4), suggesting that both
mechanisms likely contribute to IL-1b repression. These data fit
with previous work in GRdim/dim mice showing that endogenous
GCs weakly slow early healing in comparison to the drastic effects
of exogenous GCs [28]. In these experiments, GRdim/dim mice had
increased levels of IL-1b mRNA and minor changes in IL-6
mRNA 1 d after wounding [28]. Our data show that the
constitutive expression of GR and GR-TR restricted to keratino-
cytes has a profound impact on wound healing, similar to the
effects of exogenous GCs (Fig. 3).
In agreement with the role of several growth factors such as
KGF, TGF-b1 and -b3 in normal repair, we detected their
induction in WT upon wounding (Fig. 4C). Previous findings
suggested that impaired expression of TGF-bs was associated with
the wound healing defects associated with GC treatment and
diabetes in rodents [15]. We detected TGF-b1 and KGF
repression in K5-GR but not in K5-GR-TR mice. However,
TGF-b3 was induced in the wounds of both transgenic mice.
Overall, our data suggest that the different healing kinetics
documented in K5-GR vs K5-GR-TR mice may be accounted for
by the distinct patterns in gene expression regulated by each
transgene (Fig. 4C).
It is known that the GR-TR mutant used in this study is not
completely TA-deficient but a mutant with impaired GR-
mediated transcription [12]. Nonetheless, our results support
the idea that the TA function of GR is linked to the unwanted
side-effects associated with this receptor. The re-epithelialization
rate at d4 was greatly reduced in both K5-GR and K5-GR-TR
mice relative to WT as a consequence of the inhibition of
keratinocyte proliferation and migration (Figs. 2 and 4). In
addition, both GR and GR-TR transgenes were able to inhibit
migration of cultured keratinocytes at an early timepoint, similar
to the reported effects of Dex treatment [22,29]. These results
suggest that the effects of GR on keratinocyte migration are
mediated by its TR function. Our data are compatible with
wound scratch experiments performed in cultured GRdim/dim
fibroblasts showing increased proliferation and migration relative
to WT [28]. On the other hand, GR and GR-TR had different
effects on tissue remodeling given the reduction in dermal
collagen deposition in K5-GR relative to K5-GR-TR mice
(Fig. 1), consistent with the known effects of GR on collagen
synthesis and deposition [17]. These results are in agreement with
data reported in GRdim/dim wounds, which exhibited an extended
granulation tissue at d5 after injury without changes in collagen
or tenascin-C [28].
It has been reported that keratins K6 and K16, which play an
important role in keratinocyte migration, are transcriptionally
down-regulated by GR through different mechanisms [30]. These
include the interference of GR with the MAPK signaling pathway,
as previously shown in transgenic mice with GR gain- and loss-of-
function [21,22]. In WT mice, k6 mRNA is induced upon
wounding through AP-1 sites at its promoter. GR represses this
transcript by negatively interfering with AP-1 as well as through
direct binding of four GR monomers to nGREs in the k6 promoter
[31]. Another proposed mechanism for K6 repression involves the
nuclear localization of b-catenin and its stabilization upon GR
activation, leading to c-myc induction in chronic wounds [23].
The activation of b-catenin/c-myc would contribute to delayed
wound healing by inhibiting migration and altering keratinocyte
differentiation. In agreement with this, we have detected nuclear
b-catenin in K5-GR and K5-GR-TR keratinocytes in vivo at early
stages of wound healing (Fig. 5). The cross-talk between GR and
b-catenin, which interact in vitro, suggests a relevant role of Wnt-
mediated signalling in the therapeutical actions of GCs [32].
It is known that ERK phosphorylation followed by its
translocation to the nucleus is critical for the G1 to S phase
transition, leading to cell proliferation [33]. In addition, the
activation of ERK leads to induction of cyclin D1 [33]. In other
cell types, it has been reported that ligand-activated GR suppresses
phosphorylation of ERK1 and cyclin D1 expression, resulting in
cell growth inhibition [34]. Our findings are in agreement with this
and suggest that GR/ERK interference and the down-regulation
of c-Fos and cyclin D1 contributes to the impaired healing
response of both K5-GR and K5-GR-TR mice. Furthermore, the
diminished transcript levels of several genes that are AP-1 targets
including Tnf-a, Il-1b, and Tgf-b1 support a role of reduced AP-1
activity in delayed wound healing (Figs. 4 and 5). In summary,
through study of the K5-GR and K5-GR-TR mouse models, we
have shown that the TR function of GR is sufficient for inhibition
of the early stages of wound healing, likely through inhibition of
MAPK signaling and AP-1 dependent transcription. In contrast,
the TA function of GR is required for repression of later stages of
wound closure likely due to suppression of tissue remodelling. The
decreased efficiency of inhibition of ERK phosphorylation exerted
by GR-TR relative to GR both in vivo and in vitro may allow for
more rapid wound closure (Figs. 5 and 6). In this regard, the
differential inhibition of ERK activity between the transgenic lines
may explain the observed differences in their wound healing
kinetics.
Given the high prevalence of skin diseases and the wide use of
GCs for their treatment, the selective modulation of GR function
is a major therapeutic objective. The development of non-steroidal
selective GR agonists or SEGRAs in the recent years is based on
the ability of these compounds to dissociate the TA vs TR
properties of GR [35]. In this regard, our observations that
epidermal expression of the GR-TR mutant is less deleterious to
wound healing than WT GR suggest that the use of SEGRA
compounds mimicking GR-TR could be beneficial. The selective
activation of GR-TR should elicit a partial inhibition of ERK and
minor repression of pro-inflammatory cytokines and growth
factors relative to activation of both TA and TR functions, thus
contributing to improved re-epithelialization and remodeling. The
use of SEGRA compounds mimicking GR-TR could achieve a
better benefit/risk ratio by minimizing delayed wound healing,
one of the most common adverse side-effects associated to
prolonged GC treatment.
Materials and Methods
Ethics Statement
All mice were handled in accordance with the current Spanish
and European regulations which govern research with animals
(Real Decreto 1201/2005, B.O.E. #252, 10 of October, 2005 and
Convenio Europeo 1-2-3 del 18/3/1986), and approved by the
Ethic Committee of the Spanish Research Agency Consejo
Superior de Investigaciones Cientı´ficas CSIC. All projects granted
by the Spanish Ministery need to be approved by the institution’s
Ethic Committee and this is granted by the approval ID of the
project SAF2008-00540.
Animals and wounding experiments
K5-GR and K5-GR-TR mice have been previously reported
[18,19]. Both transgenic lines were generated in a C57Bl6/
DBA//F2 genetic background and maintained by backcrosses
with C57Bl6/DBA//F1 mice (Harlan). Cutaneous wounding was
performed in 12 week old female mice of the indicated genotypes,
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using WT littermates (C57Bl6/DBA//F2) as controls. At least 16
mice of each genotype were used for each timepoint. Where
indicated, WT mice (n = 6) were treated either with vehicle or Dex
(Sigma, St. Louis, MO, 1 mg/kg body weight, injected subcuta-
neously) daily for 7 d before wounding. The treatment was
continued for another 9 d after wounding and then, mouse dorsal
skin was shaved and wounds were collected.
Full-thickness wounds were performed by using 6 mm diameter
punches (Biopsy punch, Stiefel). The percentage of wound closure
was quantitated at different timepoints (d0, d4, d8) by tracing the
perimeter of the healing wound onto saran wrap, as previously
described [36]. Following sacrifice, cutaneous wounds were
collected for histopathological analysis, and isolation of RNA
and proteins.
For preparation of mouse primary keratinocytes for wound
scratch assays, skin from newborn mice of each genotype (n = 21)
was excised and processed, as previously described [21]. Following
overnight culture in EMEM 1% FBS, confluent dishes of cells
were treated with mitomycin C (Sigma, 10 mg/ml) for 1 h before
wounding. Scratch wounds were made in cell monolayers with
sterile yellow pipette tips. Following wounding, cultures were
photographed at 8 h and 24 h to quantitate keratinocyte
migration [22]. The area that remained uncovered by the cells
was quantitated and divided by the area of the original scratch to
calculate the percentage of cell migration into the wound. (Adobe
Acrobat 8 Professional). Six images were analyzed per condition
and time-point.
Antibodies
The antibodies used included rabbit polyclonal antibodies
against GR (sc-1004), b-catenin (sc-7199), ERK (sc-154), c-Fos (sc-
52), and Akt (sc-1619) from Santa Cruz Biotechnology, Inc.,
(Santa Cruz, CA). Antibodies against keratin K6 (PRB-169P) and
K10 (PRB-159P) were from Covance (Babco, Berkeley, CA), anti-
p-ERK (Thr202/Tyr204) (#4376) and p-Akt (ser-473) (#9271)
were purchased from Cell Signaling (Cell Signaling Technology
Inc., Beverley, MA). F4/80 antibody was from AbD serotec
(MorphoSys, Oxford, UK), Ly6G from BD Pharmingen, anti-
TNF-a from Calbiochem, and anti-actin (A2066) was from Sigma.
Secondary peroxidase-conjugated anti-rabbit and anti-goat anti-
bodies were from Amersham (Aylesbury, UK) and secondary
peroxidase-conjugated anti-mouse antibody was from Jackson
ImmunoResearch (Jackson ImmunoResearch Laboratories, Inc.
West Grove, PA). Secondary biotin-conjugated anti-rabbit or anti-
mouse antibodies were from Jackson ImmunoResearch.
Histological and Immunohistochemical analysis
Cutaneous wounds were collected at the indicated timepoints,
fixed in 70% ethanol, bisected through the center of the wound
and both halves of the wound were embedded in paraffin to obtain
4 mm-thick sections, and then stained with H&E.
To compare the histopathology of the lesions the sections were
selected with the largest diameter along the center of the wound.
The width between epithelial edges and between wound edges
(dermis edges) was measured using photographs of the wound
sections and Adobe Acrobat 8 Professional. The re-epithelializa-
tion rates were then calculated by using the formula: re-
epithelialization = ([distance between opposing dermis edges –
distance between opposing epithelium edges]/distance between
opposing dermis edges)6100%, as previously described [20].
For immunohistochemistry, paraffin sections were blocked with
5% fetal bovine serum, and then incubated with primary antibody
for at least 1 h. Slides were washed three times with PBS, and then
incubated with conjugated secondary antibodies for 1 h. Finally,
the reaction was visualized with the Avidin-Biotin- Complex
(ABC) kit from DAKO (Vectastain Elite, Vector Laboratories, Inc,
Burlingame, CA) using diamino-benzidine as chromogenic
substrate for peroxidase. Trichrome staining was performed by
using a commercial kit from Sigma (HT15-1KT). Slides were
mounted and analyzed by light microscopy (Leica DM RXA2),
and images were taken at the indicated magnification.
In vivo epithelial BrdU labeling
Epithelial cell proliferation was measured by i.p. injection of
BrdU (130 mg/g of body weight, Roche) into mice 1 h before
sacrifice. BrdU incorporation was detected by immunohistochem-
istry of paraffin-embedded sections using a mouse anti-BrdU
monoclonal antibody (biotest, Roche) followed by hematoxylin
counterstaining. The number of BrdU-positive cells and the
number of total cells was determined per 200 mm of interfollicular
epithelium in each section. Experiments were performed at least in
five individuals of each genotype and differences were assessed by
using the ANOVA test.
RNA preparation and quantitative RT-PCR
Total RNA was isolated from wounds of transgenic and control
littermates (five animals of each genotype) by using Trizol reagent
(Invitrogen, Molecular Probes, Eugene, Oregon), following
manufacturer’s recommendations. Reverse transcription was
performed by using 1 mg of RNA and oligo-dT (Fermentas Inc.,
Burlington, Canada) followed by quantitative PCR using specific
oligonucleotides for the genes indicated and FastStart Universal
SYBR Green Master ROX (Roche, Indianapolis, IN) in an
Applied Biosystems 7500 Fast real time PCR system (Applied
Biosystems, Foster City, CA). Oligonucleotide sequences are as
follows: TNF-a (forward: 59-ATG AGC ACA GAA AGC ATG
ATC-39; reverse: 59-TAC AGG CTT GTC ACT CGA ATT-39),
IL-1b (forward: 59-ATG GCA ACT GTT CCT GAA CTC ACC
T-39; reverse: 59-CAG GAC AGG TAT AGA TTC TTT CCT
TT-39), TGF-b1 (forward: 59-CTT CAG CTC CAC AGA GAA
GAA CTG-39; reverse: 59-CAC GAT CAT GTT GCA CAC
TGC TCC-39), TGF-b3 (forward: 59-TGG CGG AGC ACA
ATG AAC TGG-39; reverse: 59-CCT TTG AAT TTG ATT
TCC ATC-39), and Kgf (forward: 59-TGC AGC AAC TGG CCT
TGT CAC-39; reverse, 59-TCC AAC TGC CAC GGT CCT
GAT-39). At least five individual were used per genotype and
timepoint, and technical triplicates were assessed to calculate the
mean value 6 SD. Statistically significant changes were deter-
mined by performing an ANOVA test.
Immunoblotting
Whole-cell protein extracts were prepared, boiled in Laemmli
buffer, separated on 10% SDS-PAGE, and then transferred to
nitrocellulose filters (Hybond ECL; Amersham), as previously
described [21]. Membranes were analyzed using the enhanced
chemiluminescence method (ECL, Amersham), according to the
manufacturer’s recommendations. The membranes were also
stained with Ponceau S (Sigma) to verify equal protein loading
and transfer. Actin was used as a loading control. Specific bands
were scanned by using HP Scanjet G4010, quantitated with
ImageJ (National Institutes of Health), normalized to actin, and
plotted on a bar graph. Values for WT samples (d0 after
wounding) were arbitrarily set as 100, and the other experimental
groups expressed as relative to WT. Experiments were performed
in at least three individuals of each genotype, and differences were
assessed by using ANOVA test, with statistical significance when
p,0.05.
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Supporting Information
Figure S1 Specificity of TNF-a immunostaining. The dorsal
skin of adult WT mice was topically treated with either vehicle
(untreated) or PMA (8 mg) for 2 weeks, and immunostaining using
a secondary antibody only (left) or TNF-a antibody (right) was
performed. Representative images of three independent experi-
ments are shown.
(TIF)
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